Background illustration for clinical trials search

Paid Clinical Trials Vancouver

Discover 729 paid clinical trials in Vancouver, British Columbia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

for
Oligometastatic Disease, Oligoprogression,
Location: Vancouver, Surrey, Kelowna, Prince George,
Sponsor: Robert Olson

Sex: All

Age: 18+

Code: NCT05784428

Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: Vancouver, Seattle WA, Portland OR, Reno NV,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase3, Recruiting

Evaluation of Technological Innovation in Radiotherapy

for
Cancer, Radiotherapy Side Effect
Location: Vancouver, Kelowna, London, Toronto, Laval, Montreal,
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT03378856

Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Vancouver, Bellingham WA, Sedro-Woolley WA,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Vancouver, Edmonds WA, Seattle WA, Kirkland WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04269902

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Vancouver, Seattle WA, Portland OR, Oregon City OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase2, Phase3, Recruiting

(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

for
Breast Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: Female

Age: 18 - 70+

Code: NCT02627703

Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Vancouver, Vancouver WA, Salem OR, Eugene OR, Edmonton,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

for
H3 K27M, Glioma
Location: Vancouver, Calgary, London, Toronto, Ottawa, Montreal
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 0+

Code: NCT05580562

Phase3, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Vancouver, Seattle WA, Calgary, San Francisco CA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase2, Recruiting

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

for
Brain Metastases
Location: Vancouver, Portland OR, Calgary, Edmonton,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03550391

Phase3, Recruiting

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

for
Metastatic Tumor
Location: Vancouver, London, Montreal
Sponsor: David Palma

Sex: All

Age: 18+

Code: NCT05717166

Phase3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Vancouver, Tacoma WA, Grand Junction CO, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Vancouver, Tacoma WA, Wenatchee WA, Vancouver WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase3, Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: Vancouver, Seattle WA, Calgary, Red Deer, Edmonton,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase3, Recruiting

Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer

for
Urothelial Carcinoma
Location: Vancouver
Sponsor: Tampere University Hospital

Sex: All

Age: 18 - 70+

Code: NCT06310759

Recruiting

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

for
Bladder Cancer
Location: Vancouver
Sponsor: Vancouver Coastal Health

Sex: All

Age: 18+

Code: NCT00959868

Phase1, Recruiting

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

for
Prostate Cancer
Location: Vancouver, Seattle WA, Sacramento CA, Ann Arbor MI,
Sponsor: University of British Columbia

Sex: Male

Age: 18+

Code: NCT04812366

Phase2, Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Vancouver, Madison WI, Chicago IL, Greenwood IN, London,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase2, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Vancouver, Portland OR, Calgary, Salt Lake City UT,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting